𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines

✍ Scribed by Toru Shiratsuchi; Hiroaki Ishibashi; Kanemitsu Shirasuna

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
241 KB
Volume
193
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Invasive squamous cell carcinoma (SCC) cells degrade extracellular matrix (ECM) via an extracellular protease cascade that includes urokinase‐type plasminogen activator (uPA), plasmin, and the metalloprotease (MMP) family of collagenases. In this study, treatment of oral SCC cells with epidermal growth factor (EGF) stimulated the cells to invade Matrigel (constructive basement membrane (BM) protein). EGF‐induced cell invasion was inhibited by antibodies to uPA and by synthetic uPA inhibitors. EGF also induced increased expression of uPA and uPA receptor (uPAR) proteins and mRNA, as well as transcription factor activator protein‐1 (AP‐1)–DNA binding. These EGF‐induced changes were inhibited by treatment with dexamethasone (DEX). DEX treatment also stimulated the production of plasminogen activator inhibitor type 1. Moreover, transfection of SCC cells with AP‐1 decoy oligodeoxynucleotides (ODNs) resulted in the suppression of EGF‐induced uPA and uPAR expression and Matrigel invasion. These results suggest that oral SCC cells invade Matrigel mainly through the uPA‐plasmin cascade, which is mediated by the transcription factor AP‐1. The uPA–uPAR interaction is essential for augmenting proteolytic activity and uPAR‐mediated signaling, which ultimately induce motility and invasion. Since DEX inhibits the expression of both uPA and uPAR, it may be a useful treatment for oral SCC. J. Cell. Physiol. 193: 340–348, 2002. © 2002 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Inhibition of chemomigration of a human
Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function
✍ Zolfaghari, Ali; Djakiew, Daniel 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

Chemoattractants expressed at bony sites and pelvic lymph nodes are thought to promote the preferential metastasis of human prostate tumor cells to these organs. Epidermal growth factor (EGF) is a potent chemoattractant for several human metastatic prostate tumor cell lines, including the TSU-prl ce

Overexpression of epidermal growth facto
Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion
✍ Pornchai O-Charoenrat; Peter Rhys-Evans; Helmout Modjtahedi; William Court; Gary 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 277 KB 👁 3 views

Numerous reports have shown an association between overexpression of the epidermal growth factor receptor (EGFR), and poor prognosis in head and neck squamous cell carcinomas (HNSCC), however, the underlying mechanisms are still unclear. In the present study, we set out to determine whether EGFR exp

Decreased mitogenic response to epiderma
Decreased mitogenic response to epidermal growth factor in human squamous cell carcinoma lines overexpressing epidermal growth factor receptor owing to limiting amounts of the adaptor protein Grb2: Rescue by retinoic acid treatment
✍ David L. Crowe; Kenneth J. Tsang 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Growth factor receptors of the tyrosine kinase family regulate proliferation of a variety of cell types. In some human cancers, the epidermal growth factor receptor (EGFR) and its ligands often are overexpressed, leading to both constitutive and autocrine activation. Intracellular signa

Effects of pharmacologic antagonists of
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines
✍ Caren C. Bancroft; Zhong Chen; Jason Yeh; John B. Sunwoo; Ning T. Yeh; Sadhana J 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 296 KB 👁 2 views

## Abstract We previously reported that expression of angiogenesis factors interleukin‐8 (IL‐8) and vascular endothelial growth factor (VEGF) is promoted by coactivation of transcription factors nuclear factor‐kappaB (NF‐κB) and activator protein‐1 (AP‐1) by interleukin‐1α in human head and neck sq

Constitutive activation of transcription
Constitutive activation of transcription factors NF-κB, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines
✍ Frank G. Ondrey; Gang Dong; John Sunwoo; Zhong Chen; Jeffrey S. Wolf; Caren V. C 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 1 views

We previously reported that human head and neck squamous cell carcinomas (HNSCCs) express the proinflammatory and pro-angiogenic cytokines interleukin (IL)-1a, IL-6, IL-8, and granulocyte-macrophage colonystimulating factor in vitro and in vivo. The promoter region of the genes encoding these cytoki

Inhibition of proliferation in human MNN
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone : Effects on insulin-like growth factor II
✍ Ryszard Braczkowski; Andrew V. Schally; Artur Plonowski; Jozsef L. Varga; Kate G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

## Abstract ## BACKGROUND Antagonists of growth hormone‐releasing hormone (GH‐RH) can inhibit the proliferation of various tumors either indirectly through the suppression of the pituitary growth hormone/hepatic insulin‐like growth factor I (__IGF‐I__) axis and the lowering of serum __IGF‐I__ conc